Controlling Drug Expenditure in Canada

This document addresses problems, causes, solutions, and choices concerning the control of drug expenditure. It looks at the origins, evolution, and rationale of government intervention in the Ontario drug market; dispensing fees, professional services, and patient/consumer co-payments; drug reimbursement systems; brand-name firm marketing strategies; and promoting cost-effective prescribing.